Login Register
English
0

Cart

$ 0

Bioactive ROS-Responsive Nanotherapeutics Attenuate Intermittent Hypoxia-Induced Cognitive Impairment via NRF2/KEAP1/HO-1 Signaling.(A23620-4)

Date:2026-03-03 Views:34